SEC Form EFFECT filed by Gamida Cell Ltd.
$GMDA
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2024 |
| Accession Number: | 0001213900-24-041279 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||